Pharmacokinetics and outcome of high-dose melphalan followed by autologous stem cell transplantation in dialysis-dependent patients with multiple myeloma

High-dose melphalan followed by autologous stem cell transplantation (ASCT) remains the standard of care for fit patients with multiple myeloma (MM). However, individuals who are dependent on hemodialysis are frequently excluded from ASCT. Recommendations on chemotherapy dosing and hemodialysis sche...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Rabea Mecklenbrauck, Bernhard M.W. Schmidt, Heike Bähre, Annamaria Brioli, Arnold Ganser, Florian H. Heidel, Felicitas Thol
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	Elsevier 2025-01-01
Serie:	Leukemia Research Reports
Soggetti:	Multiple myeloma Autologous stem cell transplantation High-dose melphalan Hemodialysis
Accesso online:	http://www.sciencedirect.com/science/article/pii/S221304892500024X
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!